TickerGuard
Buy Day today: Neutral (57) Mixed market breadth · no major macro event
TMO

Thermo Fisher Scientific Inc

Healthcare · Diagnostics & Research

658.00$ +0.9% vs. previous close Closing price · As of: Oct 9, 2026

Statements

Cash Flow

Thermo Fisher Scientific Inc (TMO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at 2,125 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow TMO
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
772 1,206 362 848 929 1,867 78 1,444 1,220 1,801 649 1,294 1,117 1,913 356 1,886 2,708 3,339 1,978 2,227 2,650 2,688 2,202 1,528 1,937 3,487 729 1,540 2,414 3,723 1,251 1,960 2,166 3,290 723 1,399 2,239 3,457 1,192 2,125 9,013
433 474 465 478 517 574 575 571 563 558 555 571 575 576 574 574 575 602 621 660 628 683 859 836 838 848 859 855 853 839 836 790 740 740 706 685 662 728 736 816 2,942
35 32 33 38 45 43 43 48 46 44 44 52 42 43 46 47 52 51 51 51 51 77 78 77 77 75 76 -76 -150 61 70 84 68 79 75 81 70 84 83 82 319
-154 -24 -209 -124 -106 -508 -75 87 -193 -4.0 -76 -711 166 236 37 -189 -35 75 341 -133 -117 695 3.0 -123 -32 -18 111 41 -145 – – – – – – – – – – – –
13 95 -618 -126 -19 1,248 -1,025 15 106 374 -677 286 -363 135 -1,075 341 226 113 -1,321 -126 237 -348 -875 -849 -367 1,042 -1,533 -718 -9.0 1,723 -787 -216 30 594 -1,425 -726 2,151 489 -1,112 1,112 2,640
81 134 93 88 111 215 118 183 173 284 201 220 216 289 253 269 366 586 628 540 524 831 640 506 547 550 458 284 332 405 347 301 272 480 362 294 404 465 376 450 1,695
-4,196 -88 -382 -95 -6,968 -283 -179 -185 -168 -721 -181 -769 -198 -339 -260 -259 -365 -626 -1,998 -626 -616 -18,692 -670 -419 -545 -2,159 -3,142 -3,585 -4,766 -376 -2,030 -253 -3,578 20 -527 -288 -4,123 891 -8,961 164 -12,029
60 59 59 59 59 60 60 69 69 68 68 76 77 76 76 87 87 87 87 103 102 103 103 117 118 117 117 135 135 136 135 149 150 149 149 162 163 162 162 175 662
5,453 -250 -500 -250 1,699 750 1,306 39 -250 -250 -750 -750 -250 -750 -1,500 -1,500 -1,500 -31 -2,000 -2,000 -2,000 -101 -2,000 49 -6.0 -1,000 -3,000 -3,000 -3,000 0.0 -3,000 0.0 -3,000 -1,000 -2,000 -2,000 2,000 -3,000 -3,000 -1,000 -5,000
4,778 -1,894 382 -695 4,442 -1,102 -271 -976 -575 266 -688 725 -1,736 294 2,245 1,213 -710 -1.0 -2,804 -1.0 3,120 8,596 -1,008 -1,825 -1.0 3,488 504 -1,325 1,972 – – – -1,107 -2,500 2,002 -787 498 3,634 4,215 -389 7,958
4,753 -2,192 -119 -964 6,081 -1,144 -342 -1,006 -876 -13 -1,425 690 -1,869 -514 619 1,180 -791 -49 -4,850 -76 3,040 8,467 -3,145 -1,905 -151 2,391 -2,593 -1,456 1,855 -1,428 -1,821 -114 -1,190 -3,666 -102 -991 -632 3,526 1,093 -2,571 1,416
1,307 -1,184 -74 627 129 603 -386 -19 155 1,006 -989 1,186 -1,009 1,117 588 2,827 1,733 2,766 -4,733 1,432 5,013 -7,557 -1,712 -874 1,029 5,603 -5,037 -347 3,015 1,929 -2,577 1,578 -2,427 -630 131 431 -2,592 7,868 -6,599 -183 -1,506
691 1,072 268 760 817 1,651 -40 1,261 1,047 1,517 448 1,074 901 1,624 103 1,617 2,342 2,753 1,350 1,687 2,126 1,857 1,562 1,022 1,390 2,937 271 1,256 2,082 3,318 904 1,659 1,894 2,810 361 1,105 1,835 2,992 816 1,675 7,318

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?